Zabofloxacin Hydrochloride

N/A

Report date: 2022/11/25 14:09:10
NME

Base Information

Drug NameZabofloxacin Hydrochloride
Drug Alias Namezabofloxacine扎波沙星zabofloxacinozabofloxacinumZrumgil +[11] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsCommunity Acquired PneumoniaPulmonary Disease, Chronic Obstructive
Global Approved IndicationsPulmonary Disease, Chronic Obstructive
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2015/03/20
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDong Wha Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDong Wha Pharm Co Ltd
Inactive CompaniesIaso Pharma Inc
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsCommunity Acquired Pneumonia

Other Information

ATC CodeJ01MA
Related LinksWikipediaDrugBank